11. Anderson, S. E.Jr.,and J. S. Remington. 1974. Effectof
normal and activated human macrophages on Toxoplasma
gondii. J. Exp. Med. 139r11.54.
12. Sharma, S. D., J. R. Catterall, and J. S. Remington. 1986.
Parasiticidal activity of macrophages against Toxoplasma.
Methods Enzymol. 132.~526.
13. Adams, L., J. H. Hibbs, R. R. Taintor, and J. L. Krahenbuhl.
1990. Microbiostatic effect of murine-activated macrophages
for Toxoplasma gondii. Role for synthesis of inorganic ni- trogen oxides from L-arginine. J. Immunol. 144:2725.
14. Sibley, L. D., L. Adams, Y. Fukutomi, and J. L. Krahenbuhl.
1992. Tumor necrosis factor-a triggers antitoxoplasmal ac- tivity of IFN-y primed macrophages. J . Imrnunol. 147:2340.
15. Langermans, J. A. M., M. E. B.Van der Hulst, P.H. Nibbereing, P. s. Hiemstra, L. Fransen, and R. Van Furth. 1992.
IFN-y-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-a. J . Immunol. 148:568.
16. Lyons, C. R., G. J. Orloff, and J. M.Cunningham. 1992.
Molecular cloning and functional expression of an inducible
nitric oxide synthase from a murine macrophage cell line. J .
Biol. Chem. 267:6370.
17. Wynn, T. A., C. M. Nicolet, and D. M. Paulnock. 1991. Identification and characterization of a new gene family induced
during macrophage activation. J. Immunol. 147:4384.
18. Svetic, A., E D. Finkelman, Y. C. Jian, C. W. Dieffenbach, D.
E. Scott, K. F. Maccarthy, A. D. Steinberg, and W. C. Gause.
1991. Cytokine gene expression after in vivo primary im- munization with goat antibody to mouse IgD antibody. J .
Immunol. 147:2391.
19. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular
Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
20. Hunter, C. A., C. W. Roberts, M. Murray, and J. Alexander.
1992. Detection of cytokine mRNA in the brains of mice with
toxoplasmic encephalitis. Parasite Immunol. 14.405.
21. Murray, H. W., J. K. Hillman, B. Y. Rubin, C. D. Kelly, J. L.
Jacobs, L. W. Tyler, D. M. Donelly, S. M. Carriero, J. H.
Godbold, and R. B. Roberts. 1985. Patients at risk for AIDSrelated opportunistic infections: clinical manifestation and
impaired gamma interferon production. N. Engl. J. Med. 313:
1504.
22. Chang, H.R., G. E. Grau, and J.C. Pechere. 1990. Role
of TNF and IL-1 in infections with Toxoplasma gondii.
Immunology 69:33.
23. Johnson, L. L. 1992. A protective role for endogenous tumor
necrosis factor in Toxoplasma gondii infection. Infect.
Immun. 60:1979.
24. Grau, G. E., L. F. Farjardo, P.F. Piguet, B. Allet, P. H. Lambert, and P. Vassali. 1987. Tumor necrosis factor (cachectin)
as an essential mediator in murine cerebral malaria. Science
237:1210.
25. Grau, G. E., H. Heremans, PF.. Piguet, P. Pontaire, P. H.
Lambert, A. Billiau, and P. Vassali. 1989. Monoclonal antibody against interferon-gamma can prevent experimental ce- rebral malaria and its associated over-production of tumor
necrosis factor. Proc. Natl. Acad. Sci. USA 86:5572.
26. Freund, Y. R., G. Sgarlato, C. 0. Jacob, Y. Suzuki, and J. S.
Remington. Polymorphysms in the tumor necrosis factor a
(TNF-a) gene correlate with murine resistance to development of toxoplasmic encephalitis and with levels of TNF-a
mRNA in infected brain tissue. J . Exp. Med. 175:683.
